Skip to main content
Clinical Trials/NCT02223130
NCT02223130CompletedNot Applicable

Addressing Discrimination and Mistrust Among Black Men: Phase III

Boston Children's Hospital2 sites in 1 country64 target enrollmentStarted: July 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
64
Locations
2
Primary Endpoint
Coping

Study Overview

Brief Summary

The purpose of this research study is to test a group program aimed at improving the quality of life of HIV+ Black men who have sex with men. The group will address ways to cope with discrimination and will help men examine mistrust that they may have about healthcare, including doctors and other healthcare providers and HIV medications. The aim is to provide a supportive community for HIV+ Black men.

Detailed Description

The aim of the study is to examine whether the pilot intervention can reduce mistrust and improve coping responses to discrimination among HIV positive Black men who have sex with men (MSM). We will conduct a small randomized pilot trial to test the feasibility of evaluation methods. All participants will attend a baseline, a first follow-up visit, and a final follow-up visit (each 3 months apart) at which they will take computer assessments. Participants who are assigned to the intervention will attend 9 weekly intervention sessions after baseline and before the first follow-up. Using a wait-list control design, control group participants from the first two cohorts will be offered the intervention after they complete the final follow-up visit. Control group participants from the third cohort will be offered the intervention after they complete the first final-up visit and before they complete their final follow-up due to timing and budgetary restraints. We will hold three consecutive groups for our small randomized control trial. This means that we will be recruiting continuously; once we finish recruiting for the first group, we will start recruiting for the second group, and so on. Each group has about 12 or 13 intervention and 7-11 control participants.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years-old or older
  • Biologically male at birth
  • Currently self-identifies as male
  • Self-identifies as Black or African American (mixed-race individuals will be eligible if they primarily identify as Black or African American)
  • HIV-positive
  • Reported having sex with men in lifetime
  • Able and willing to provide informed consent

Exclusion Criteria

  • Does not meet all of the inclusion criteria (e.g., if they are unable to provide proof of their HIV-positive status)
  • Unable to provide informed consent
  • Reports or presents evidence of severe mental health problems that require immediate treatment (e.g., psychotic symptoms, active suicidality at time of enrollment) or diagnosed mental disorder that would limit the ability to participate (e.g., dementia)
  • Reports or presents evidence of cognitive impairments that limit the ability to comprehend the informed consent or to fully participate in the various parts of the study (assessments, intervention, homework).

Outcomes

Primary Outcomes

Coping

Time Frame: 3 months post-baseline

Improved coping scores on Brief Cope, Emotional and Behavioral Coping, and Africultural Coping scales

Secondary Outcomes

  • Mistrust(3 months post-baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Laura Bogart

Associate Professor of Pediatrics, Harvard Medical School; Research Director, Division of General Pediatrics, Boston Children's Hospital

Boston Children's Hospital

Study Sites (2)

Loading locations...

Similar Trials

Addressing Discrimination and Mistrust... | Clinical Trial